MetaCap

Oric Pharmaceuticals Cash Flow Statement

NASDAQ: ORICHealth CareBiotechnology: Pharmaceutical PreparationsUSD

11.99-0.04 (-0.33%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Oric Pharmaceuticals free cash flow

In fiscal 2025, Oric Pharmaceuticals generated -$111.0 million of operating cash flow and spent $712,000 on capital expenditures. That left free cash flow of -$111.7 million.

Summary generated from market data by MetaCap's automated system. Methodology

Oric Pharmaceuticals cash flow statement (annual)

Oric Pharmaceuticals annual cash flow statement
Fiscal year (USD)FY 20252025-12-31FY 20242024-12-31FY 20232023-12-31FY 20222022-12-31FY 20212021-12-31FY 20202020-12-31FY 20192019-12-31FY 20182018-12-31
Net Income-129.47M-127.85M-100.70M-89.12M-78.72M-73.70M-26.88M-21.36M
Net Income growth (YoY)————————
Depreciation & Amortization1.22M1.11M1.03M966.00K897.00K970.00K1.03M903.00K
Stock-Based Compensation25.04M20.21M15.23M14.46M12.85M5.28M1.09M469.00K
Change in Working Capital-5.46M1.97M4.90M-445.00K4.07M2.04M1.22M-707.00K
Operating Cash Flow-110.97M-112.66M-85.69M-75.14M-59.54M-45.27M-23.53M-20.68M
Capital Expenditures-712.00K-1.19M-849.00K-2.08M-939.00K-667.00K-768.00K-525.00K
Investing Cash Flow-148.03M22.14M-43.40M-109.25M158.44M-215.96M-768.00K-508.00K
Financing Cash Flow245.26M126.55M85.66M25.23M49.13M250.51M70.82M38.01M
Net Change in Cash-13.74M36.02M-43.43M-159.17M148.03M-10.71M46.52M16.82M
Free Cash Flow-111.68M-113.85M-86.54M-77.22M-60.48M-45.94M-24.30M-21.21M

This table shows 8 annual periods of Oric Pharmaceuticals's cash flow statement, from FY 2025 back to FY 2018, across 10 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow ORIC's reporting calendar. What is a cash flow statement?

More financial data